Are we missing tracks while prescribing proton pump inhibitors? - An opinion from clinicians cross sectional hospital based questionnaire study

Abstract

Introduction Poton pump inhibitors are the main stage standard therapy for various gastrointestinal disorders such as upper gastrointestinal disorders GERD dyspepsia and peptic ulcer disease1 The availability of PPIs as an OTC drug and its over utilization in multiple disease backgrounds with or without symptoms has subjected patients to a potential risk such as parietal cell hypertrophy and hypergastrinemia leading to rebound acid secretion2 Studies have shown that between 40 to 65 of prescriptions for a PPI fail to have an appropriate indication3 Inapt stress ulcer prophylaxis SUP in hospital wards and in the clinical OPDs and failure to discontinue SUP prior to hospital discharge has amplified this risk4Aim To analyse the views opinion and judgement of every clinicians in our hospital regarding PPI prescription and factors they consider while prescribing and their views to decrease misuse of the sameMaterials and Methods This is a crosssectional opinion deriving hospital based questionnaire study where mostly physicians of all specialities were interviewed with a prestructured questionnaire containing 14 questionsResults 93 respondents of multispeciality background had variety of opinion about the practice of the PPIs in our hospital 247 of them treat 3140 patients per month on average with genuine gastrointestinal symptoms which mandate the use of proton pump inhibitors evidently 50 of the practitioners told they will prescribe for patient satisfaction and patients request for gastric tablets 467 of the practitioners didnrsquot think of deprescribing PPIs in asymptomatic patients Nearly 70 of them were either not sure or had any idea about the deprescribing PPI useKeywords Proton pump inhibitors Prescription practice Deprescribing guidelines Long term effects

Authors and Affiliations

Shashikiran D. , Padmaja Udaykumar

Keywords

Related Articles

Academic stress reduction by Jacobson's progressive muscle relaxation: A quasi experimental study

Adolescents are the most dramatic phase, undergoing academic and social pressure which subjects them to negative emotional stress. The present study was conducted to evaluate the effectiveness of Jacobson’s progressive m...

Pharmacokinetic interaction of Phosphorus on the treatment of sputum positive pulmonary tuberculosis patients

Tuberculosis (TB) in children is a neglected aspect of the TB epidemic despite it constituting 20% or more of all TB cases in many countries with high TB incidence. Tuberculosis constitutes a serious global health proble...

Assessment of knowledge, attitude & practices towards immunization against Hepatitis B virus infection amongst medical students in a medical college in Mangalore

Introduction: Infection by Hepatitis B virus is the cause of chronic hepatitis, liver cirrhosis and hepato-cellular carcinoma worldwide. It’s estimated that almost 257 million of the world population have contracted the...

Biological activity and phytochemical screening of different extracts of Sida cordata (Burm.F.) borssum root

In the present study was designed to evaluate antimicrobial anthelminthic activity and phytochemical analysis of different extracts of Sida cordata Burm f borssum root rxtract was prepared using different solvents like c...

Application of quality by design paradigm in the design of muco-adhesive extended release film for oral ulcer

The present study deals with the formulation of mucoadhesive bilayered buccal film of lidocaine hydrochloride and benzydamine hydrochloride for treatment of oral ulcers aphthous stomatitis EudragitRLPO and Ethyl cellulos...

Download PDF file
  • EP ID EP481708
  • DOI 10.18231/2456-9542.2018.0008
  • Views 70
  • Downloads 0

How To Cite

Shashikiran D. , Padmaja Udaykumar (2018). Are we missing tracks while prescribing proton pump inhibitors? - An opinion from clinicians cross sectional hospital based questionnaire study. IP International Journal of Comprehensive and Advanced Pharmacology, 3(1), 26-30. https://europub.co.uk/articles/-A-481708